medigraphic.com
ISSN 1527-3172 (Digital)

2020, Número 1

<< Anterior Siguiente >>

MEDICC Review 2020; 22 (1)


Circulation of Human Papillomavirus and Chlamydia trachomatis

Guilarte-García E, Soto-Brito Y, Kourí-Cardellá V, Limia-León CM, Sánchez-Alvarez ML, Rodríguez-Díaz AE, López-Fuentes LX, Méndez-González M, Aróstica-Valdés N, Bello-Pérez M, Pérez-Santos L, Pintos-Saavedra Y, Baños-Morales Y

Idioma: Ingles.
Referencias bibliográficas: 72
Paginas: 17-27
Archivo PDF: 200.17 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization [Internet]. Geneva: World Health Organization; c2019. Centro de Prensa. Infecciones de transmisión sexual. Datos y cifras; 2019 Jun 14 [cited 2019 Sep 3]. Available from: http://www.who.int/mediacentre/ factsheets/fs110/es/. Spanish.

  2. zurHausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology Feb 20 [Internet]. 2009 [cited 2019 Sep 5];384(2):260–5. Available from: https://www.clinicalkey.es/service/content/pdf/ watermarked/1-s2.0-S0042682208007721 .pdf?locale=es_ES&searchIndex=

  3. Centre on HPV and Cancer. Human Papillomavirus and Related Diseases Report. Cuba. ICO Information [Internet]. Washington, D.C.: Centre on HPV and Cancer; 2018 [cited 2019 Sep 9]. Available from: https://hpvcentre.net/statistics/reports/CUB_FS.pdf

  4. de Villiers EM. Cross-roads in the classifi cation of papillomaviruses. Virology [Internet]. 2013 Oct [cited 2019 Sep 9];445(1–2):2–10. Available from: https://www.clinicalkey.es/service/content/ pdf/watermarked/1-s2.0-S0042682213002456 .pdf?locale=es_ES&searchIndex=

  5. Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, et al. Genetic variations in human papillomavirus and cervical cancer outcomes. Int J Cancer [Internet]. 2019 May 1 [cited 2019 Sep 9];144(9):2206–14. Available from: https://onlinelibrary.wiley.com/resolve/doi?DOI =10.1002/ijc.32038

  6. Santana Serrano C, Chávez Roque M, Viñas Sifontes LN, Hernández López E, Cruz Pérez J. Diagnóstico precoz del cáncer cérvicouterino. Ginecol Salud Reprod [Internet]. 1999 [cited 2019 Sep 9]; [about 4 screens]. Available from: http://www.bvs.sld.cu/revistas/gin/vol37_2_11/ gin11211.htm. Spanish.

  7. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2018 [Internet]. Havana: Ministry of Public Health (CU); 2019 [cited 2019 Sep 9]. 197 p. Available from: http://fi les.sld.cu/bvscuba/fi les/2019/04/Anuario -Electr%C3%B3nico-Espa%C3%B1ol-2018 -ed-2019-compressed.pdf. Spanish.

  8. Franceschi S, Herrero R, Clifford GM, Snijders PJF, Arslan A, Anh PTH, et al. Variations in the age-specifi c curves of human papillomavirus prevalence in women worldwide. Int J Cancer [Internet]. 2006 Dec 1 [cited 2019 Sep 10];119(11):2677–84. Available from: https:// onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.22241

  9. Soto Y, Torres G, Kourí V, Limia CM, Goicolea A, Capo V, et al. Molecular epidemiology of human papillomavirus infections in cervical samples from Cuban women older than 30 years. J Low Genit Tract Dis [Internet]. 2014 Jul [cited 2019 Sep 10];18(3):210–7. Available from: http://in sights.ovid.com/pubmed?pmid=24270200

  10. Soto Brito Y, Limia León CM, Kourí Cardellá V, Goicolea Maiza A, Capó de Paz V, Muné Jiménez M. Papilomavirus humanos y otros factores asociados al desarrollo de lesiones cervicouterinas en mujeres cubanas. Panorama Cuba y Salud [Internet]. 2016 Jan–Apr [cited 2019 Sep 10];11(1):24–33. Available from: https://www.re dalyc.org/pdf/4773/477355397005.pdf. Spanish.

  11. Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis [Internet]. 2017 Aug [cited 2019 Sep 10];17(8):e235–79. Available from: https:// linkinghub.elsevier.com/retrieve/pii/S1473 -3099(17)30310-9

  12. Llaguno Concha AA. Factores socio epidemiológicos y clínicos presentes en mujeres atendidas en consulta de infertilidad. Rev Cubana Ginecol Obstet [Internet]. 2015 [cited 2019 Sep 10];41(4):365–75. Available from: http://scielo .sld.cu/pdf/gin/v41n4/gin06415.pdf. Spanish.

  13. Granado-Martínez O, Figueroa-Mendoza M, Almaguer-Almaguer JA, López-Artze O, Arroyo- Díaz Y, Gutiérrez-Díaz M, et al. Cirugía de mínimo acceso en la infertilidad femenina. Rev Cubana Ginecol Obstet [Internet]. 2010 [cited 2019 Sep 10];36(3):368–81. Available from: http://scielo .sld.cu/pdf/gin/v36n3/gin08310.pdf. Spanish.

  14. Álvarez Miranda MC, Martín Raimundo D, Jiménez Puñales S, Pentón Cortes RJ, Cairo González VM. Cirugía tubárica endoscópica: una alternativa para el manejo de la mujer infértil en Villa Clara. Acta Médica Centro [Internet]. 2013 [cited 2019 Sep 10];7(4). Available from: http:// www.revactamedicacentro.sld.cu/index.php/ amc/article/view/21/165. Spanish.

  15. Rivero-Figueroa D, Kourí-Cardellá V, Correa-Sierra C, Martínez-Mota I, Llanes Caballero R. Barreal González RT. Detección de Chlamydia trachomatis en muestras de exudado endocervical mediante una prueba de diagnóstico rápido y dos técnicas de reacción en cadena de la polimerasa. Rev Cubana Ginecol Obstet [Internet]. 2014 [cited 2019 Sep 10];40(1):48–57. Available from: http://scielo.sld.cu/ pdf/gin/v40n1/gin06114.pdf. Spanish.

  16. Frontela Noda M, Rodríguez Marín Y, Verdejas Varela OL, Valdés Martínez FJ. Infección por Chlamydia trachomatis en mujeres cubanas en edad reproductiva. Rev Cubana Endocrinol [Internet]. 2006 [cited 2019 Sep 10];17(2). Available from: http://scielo.sld.cu/pdf/end/v17n2/ end01206.pdf. Spanish.

  17. Kourí V, Cartaya J, Rodríguez ME, Muné M, Soto Y, Resik S, et al. Prevalence of Chlamydia trachomatis in human immunodefi ciency virus-infected women in Cuba. Mem Inst Oswaldo Cruz [Internet]. 2002 Dec [cited 2019 Sep 10];97(8):1073–7. Available from: http://www.scielo.br/pdf/mioc/v97n8/4511.pdf

  18. Papanicolaou GN. A new procedure for staining vaginal smears. Science [Internet]. 1942 Apr 24 [cited 2019 Sep 11];95(2469):438–9. Available from: http://www.sciencemag.org/cgi/pmidlookup ?view=long&pmid=17842594

  19. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol [Internet]. 2009 Apr [cited 2019 Sep 11];10(4):321–2. Available from: https://www .thelancet.com/journals/lanonc/article/PIIS1470 -2045(09)70096-8/fulltext

  20. Wei HB, Zou SX, Yang XL, Yang DQ, Chen XD. Development of multiplex real-time quantitative PCR for simultaneous detection of Chlamydia trachomatis and Ureaplasma parvum. Clin Biochem [Internet]. 2012 Jun [cited 2019 Sep 11];45(9):663–7. Available from: https://linkinghub .elsevier.com/retrieve/pii/S0009-9120(12)00138-5

  21. World Medical Association. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA [Internet]. 2013 Nov 27 [cited 2019 Sep 11];310(20):2191–4. Available from: https://jamanetwork.com/journals/jama/ fullarticle/1760318?appId=scweb

  22. Van Delden JJM, Van der Graaf R. Revised CIOMS International Ethical Guidelines for health-related research involving humans. JAMA [Internet]. 2017 Jan 10 [cited Sep 11]; 317(2):135–6. Available from: https:// jamanetwork.com/journals/jama/article-abs tract/2592245

  23. Nyitray AG, Iannacone MR. The epidemiology of human papillomaviruses. Curr Probl Dermatol [Internet]. 2014 [cited Sep 12];45:75–91. Available from: https://www.karger.com/Article/ PDF/358370

  24. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA [Internet]. 2007 Feb 28 [cited 2019 Sep 12];297(8):813–9. Available from: https://jama network.com/journals/jama/fullarticle/10.1001/ jama.297.8.813

  25. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health [Internet]. 2004 Jan–Feb [cited 2019 Sep 12];36(1):6–10. Available from: https://www.guttmacher.org/pubs/jour nals/3600604.html

  26. Howell-Jones R, de Silva N, Akpan M, Oakeshott P, Carder C, Coupland L, et al. Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation. Vaccine [Internet]. 2012 Jun 6 [cited 2019 Sep 12];30(26):3867–75. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264 -410X(12)00525-7

  27. Baldauf JJ, Fender M, Akladios CY, Velten M. [Is early cervical cancer screening justifi ed?]. Gynecol Obstet Fertil [Internet]. 2011 [cited 2019 Sep 12];39(6):358–63. Available from: https://www .ncbi.nlm.nih.gov/pubmed/21600827. French.

  28. Bruni L, Díaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological fi ndings. J Infect Dis [Internet]. 2010 Dec 15 [cited 2019 Sep 12];202(12):1789–99. Available from: https://academic.oup.com/jid/article-lookup/ doi/10.1086/657321

  29. Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortés- Gutiérrez EI, Salgado-Bernabé ME, Ramos- González NP, Ortega-Cervantes L, et al. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specifi c prevalence and HPV coinfections. J Med Virol [Internet]. 2015 May [cited 2019 Sep 12];87(5):871–84. Available from: https://doi.org/10.1002/jmv.24099

  30. Villa LL. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. Int J Infect Dis [Internet]. 2007 Nov [cited 2019 Sep 13];11 Suppl 2:S17–25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1201 -9712(07)60017-4

  31. Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med [Internet]. 2015 Feb 19 [cited 2019 Sep 13];372(8):711–23. Available from: https://www.nejm.org/doi/10.1056/ NEJMoa1405044?url_ver=Z39.88-2003&rfr _id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww .ncbi.nlm.nih.gov

  32. Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, et al. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. J Clin Virol [Internet]. 2014 Jul [cited 2019 Sep 15];60(3):257–63. Available from: https://linkinghub.elsevier.com/retrieve/pii/ S1386-6532(14)00142-5

  33. Bruno A, Serravalle K, Travassos AG, Lima BG. [Genotype distribution of human papillomavirus in women from the state of Bahia, Brazil]. Rev Bras Ginecol Obstet [Internet]. 2014 Sep [cited 2019 Sep 15];36(9):416–22. Available from: http://www.scielo.br/pdf/rbgo/v36n9/0100 -7203-rbgo-36-09-00416.pdf. Portuguese.

  34. Wang XC, Sun LQ, Ma L, Li HX, Wang XL, Wang X, et al. Prevalence and genotype distribution of human papillomavirus among women from Henan, China. Asian Pac J Cancer Prev [Internet]. 2014 [cited 2019 Sep 15];15(17):7333–6. Available from: http://journal .waocp.org/article_29769_cf3b31b6ca1f24b f246ee346c8c698ca.pdf

  35. Sun B, He J, Chen X, He M, He Z, Wang Y, et al. Prevalence and genotype distribution of human papillomavirus infection in Harbin, Northeast China. Arch Virol [Internet]. 2014 May [cited 2019 Sep 15];159(5):1027–32. Available from:https://link.springer.com/content/pdf/10.10 07%2Fs00705-013-1886-1.pdf

  36. Ortega-Cervantes L, Aguilar-Lemarroy A, Rojas- García AE, Barrón-Vivanco BS, Vallejo-Ruiz V, Cantú de León D, et al. Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer. Int J Health Sci (Qassim) [Internet]. 2016 Jul–Sep [cited 2019 Sep 15];10(3):327–38. Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC5003576/pdf/ijhs-10-3-327.pdf

  37. Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer [Internet]. 2015 Sep [cited 2019 Sep 15];51(13):1732–41. Available from:http:// incan-mexico.org/wp_ginecologia/wp-content/ uploads/Human-papillomavirus-genotype-attri bution-in-female-anogenital-lesions.pdf

  38. Tabrizi SN, Brotherton JM, Stevens MP, Condon JR, McIntyre P, Smith D, et al. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. J Clin Virol [Internet]. 2014 Jul [cited 2019 Sep 15];60(3):250–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1386 -6532(14)00146-2

  39. Mejía L, Muñoz D, Trueba G, Tinoco L, Zapata S. Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women. J Med Virol [Internet]. 2016 Jan [cited 2019 Sep 15];88(1):144–52. Available from: https://onlinelibrary.wiley.com/doi/ pdf/10.1002/jmv.24310

  40. Coser J, da Rocha Boeira T, Simon D, Kazantzi Fonseca AS, Ikuta N, Lunge VR. Prevalence and genotypic diversity of cervical human papillomavirus infection among women from an urban center in Brazil. Genet Mol Res [Internet]. 2013 Feb 19 [cited 2019 Sep 12];12(4):4276–85. Available from: http://www.geneticsmr.com/articles/2101

  41. Flores-Miramontes MG, Torres-Reyes LA, Aguilar- Lemarroy A, Vallejo-Ruíz V, Piña-Sánchez P, Cortés-Gutiérrez E, et al. [HPV genotypes prevalence in Mexico and worldwide detected by Linear Array]. Rev Med Inst Mex Seguro Soc [Internet]. 2015 [cited 2019 Sep 12];53 Suppl 2:S122–30. Available from: https://www.medi graphic.com/pdfs/imss/im-2015/ims152c.pdf. Spanish.

  42. Wang SM, Colombara D, Shi JF, Zhao FH, Li J, Chen F, et al. Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses. Int J Gynecol Cancer [Internet]. 2013 May [cited 2019 Sep 15];23(4):716–23. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3636161/pdf/nihms444305.pdf

  43. Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, et al. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res [Internet]. 2010 Nov 1 [cited 2019 Sep 15];70(21):8578–86. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/pmid/20959485/

  44. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol [Internet]. 2013 May [cited 2019 Sep 15];51(5):1458–64. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/PMC3647930/pdf/ zjm1458.pdf

  45. de Sanjosé S, Wheeler CM, Quint WGV, Hunt WC, Joste NE, Alemany L, et al. Age-specifi c occurrence of HPV16- and HPV18-related cervical cancer. Cancer Epidemiol Biomarkers Prev [Internet]. 2013 Jul [cited 2019 Sep 15];22(7):1313–8. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/PMC4306595/pdf/ nihms-648924.pdf

  46. Monsonego J, Zerat L, Syrjanen K, Zerat JC, Smith JS, Halfon P. [Prevalence of genotype-specific HPV infection among women in France: implications for screening and vaccination]. Gynecol Obstet Fertil [Internet]. 2013 May [cited 2019 Sep 15];41(5):305–13. Available from: https:// www.sciencedirect.com/science/article/pii/ S1297958913000878?via%3Dihub. French.

  47. Díaz D, Santander MA, Chavez JA. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. Int J Oncol [Internet]. 2012 Jul [cited 2019 Sep 15];41(1):141–6. Available from: https://www .spandidos-publications.com/ijo/41/1/141

  48. Bodily J, Laimins LA. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol [Internet]. 2011 Jan [cited 2019 Sep 15];19(1):33–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3059725/pdf/nihms245474.pdf

  49. Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol [Internet]. 2008 Jan [cited 2019 Sep 16];82(2):1053–8. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/pmid/17989183/

  50. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet [Internet]. 2012 Mar [cited 2019 Sep 16];285(3):771–7. Available from: https://dx.doi .org/10.1007/s00404-011-2155-8

  51. Marks M, Gravitt PE, Gupta SB, Liaw KL, Kim E, Tadesse A, et al. The association of hormonal contraceptive use and HPV prevalence. Int J Cancer [Internet]. 2011 Jun 15[cited 2019 Sep 16];128(12):2962–70. Available from: https://doi .org/10.1002/ijc.25628

  52. Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M, Ryan GL. Human papillomavirus vaccination and sexual behavior in young women. J Pediatr Adolesc Gynecol [Internet]. 2014 Apr [cited 2019 Sep 16];27(2):67–71. Available from: https://linkinghub.elsevier.com/retrieve/pii/ S1083-3188(13)00280-5

  53. Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, et al. Cross-protective effi cacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis [Internet]. 2012 Oct [cited 2019 Sep 16];12(10):781–9. Available from: https://linkinghub.elsevier.com/ retrieve/pii/S1473-3099(12)70187-1

  54. Girianelli VR, Thuler LCS, e Silva GA. [Prevalence of HPV infection among women covered by the family health program in the Baixada Fluminense, Rio de Janeiro, Brazil]. Rev Bras Ginecol Obstet [Internet]. 2010 Jan [cited 2019 Sep 12];32(1):39–46. Available from: https://www .semanticscholar.org/paper/%5BPrevalence -of-HPV-infection-among-women-covered-by -Girianelli-Thuler/95ed4458cd963a7498d55eec6 d4a567eebb9bec8

  55. Zahnd WE, Rodríguez C, Jenkins WD. Ruralurban differences in human papillomavirusassociated cancer trends and rates. J Rural Health [Internet]. 2019 Mar [cited 2019 Sep 16];35(2):208–15. Available from: https://onlineli brary.wiley.com/doi/pdf/10.1111/jrh.12305

  56. Raychaudhuri S, Mandal S. Socio-demographic and behavioural risk factors for cervical cancer and knowledge, attitude and practice in rural and urban areas of North Bengal, India. Asian Pac J Cancer Prev [Internet]. 2012 [cited 2019 Sep 16];13(4):1093–6. Available from: http://journal .waocp.org/article_26298_e73d7014392683964 2144a3724161d93.pdf

  57. Wei L, Griego AM, Chu M, Ozbun MA. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis [Internet]. 2014 Oct [cited 2019 Sep 16];35(10):2373–81. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4178472/pdf/bgu156.pdf

  58. Varona P, García RG, Garcia RM, Lorenzo E. Tabaquismo y percepción del riesgo de fumar en trabajadores de la educación. Rev Cub Salud Pública 2016;42(1):45–60. Available from: https://www.scielosp.org/article/rcsp/2016 .v42n1/o6/

  59. Wiesenfeld HC. Screening for Chlamydia trachomatis infections in women. N Engl J Med [Internet]. 2017 Feb 23 [cited 2019 Sep 16];376(8):765–73. Available from: http://www .nejm.org/doi/full/10.1056/NEJMcp1412935?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref .org&rfr_dat=cr_pub%3dpubmed

  60. Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, et al. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One [Internet]. 2015 Jan 23 [cited 2019 Sep 16];10(1):e0115753. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/PMC4304822/pdf/ pone.0115753.pdf

  61. Martínez MA, Reid SI, Arias C, Napolitano RC, Sandoval ZJ, Molina CR. Prevalence of cervical infection by Chlamydia trachomatis among Chilean women living in the Metropolitan Region. Rev Med Chil [Internet]. 2008 [cited 2019 Sep 16];136(10):1294–300. Available from: https:// scielo.conicyt.cl/pdf/rmc/v136n10/art09.pdf. Spanish.

  62. Torrone E, Papp J, Weinstock H; Center for Disease Control and Prevention (CDC). Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007- 2012. MMWR Morb Mortal Wkly Rep [Internet]. 2014 Sep 26 [cited 2019 Sep 16];63(38):834–8. Available from: https://www.cdc.gov/mmwr/pdf/ wk/mm6338.pdf

  63. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One [Internet]. 2015 Dec 8 [cited 2019 Sep 16];10(12):e0143304. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4672879/pdf/pone.0143304.pdf

  64. Adams EJ, Charlett A, Edmunds WJ, Hughes G. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect [Internet]. 2004 Oct [cited 2019 Sep 17];80(5):354–62. Available from: https://sti.bmj.com/content/sex trans/80/5/354.full.pdf

  65. Underhill G, Hewitt G, McLean L, Randall S, Tobin J, Harindra V. Who has chlamydia? The prevalence of genital tract Chlamydia trachomatis within Portsmouth and South East Hampshire, UK. J Fam Plann Reprod Health Care [Internet]. 2003 Jan [cited 2019 Sep 17];29(1):17–20. Available from: https://srh.bmj.com/content/family planning/29/1/17.full.pdf

  66. Mascellino MT, Ciardi MR, Oliva A, Cecinato F, Hassemer MP, Borgese L. Chlamydia trachomatis detection in a population of asymptomatic and symptomatic women: correlation with the presence of serological markers for this infection. New Microbiol [Internet]. 2008 Apr [cited 2019 Sep 16];31(2):249–56. Available from: http://www.newmicrobiologica.org/PUB/allegati _pdf/2008/2/249.pdf

  67. Thomas P, Spaargaren J, Kant R, Lawrence R, Dayal A, Lal JA, et al. Burden of Chlamydia trachomatis in India: a systematic literature review. Pathog Dis [Internet]. 2017 Jul 31[cited 2019 Sep 17];75(5). Available from: https://www.ncbi.nlm. nih.gov/pmc/articles/PMC5808648/pdf/ftx055 .pdf

  68. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer [Internet]. 2015 Mar 1[cited 2019 Sep 17];136(5):359–86. Available from: https://on linelibrary.wiley.com/doi/pdf/10.1002/ijc.29210

  69. Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis. Medicine (Baltimore) [Internet]. 2016 Mar [cited 2019 Sep 17];95(13):e3077. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/PMC4998531/pdf/ medi-95-e3077.pdf

  70. Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, et al. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect [Internet]. 2014 Nov [cited 2019 Sep 17];90(7):550–5. Available from: https://sti.bmj.com/content/90/7/550.long

  71. Luostarinen T, Namujju PB, Merikukka M, Dillner J, Hakulinen T, Koskela P, et al. Order of HPV/Chlamydia infections and cervical highgrade precancer risk: a case-cohort study. Int J Cancer [Internet]. 2013 Oct 1 [cited 2019 Sep 17];133(7):1756–9. Available from: https://on linelibrary.wiley.com/doi/pdf/10.1002/ijc.28173

  72. Karim S, Souho T, Benlemlih M, Bennani B. Cervical cancer induction enhancement potential of Chlamydia trachomatis: a systematic review. Curr Microbiol [Internet]. 2018 Dec [cited 2019 Sep 17];75(12):1667–74. Available from: https://link.springer.com/article/10.1007%2 Fs00284-018-1439-7




2020     |     www.medigraphic.com